Strata Critical Medical, Inc.
SRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 10.4% | 54.1% | 189.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.7% | 18.7% | 15.2% | 20.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.2% | -27.1% | -47.8% | -46.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11% | -24.9% | -18.7% | -79.3% |
| EPS Diluted | -0.35 | -0.76 | -0.38 | -0.57 |
| % Growth | 53.9% | -100% | 33.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |